Dong-A Socio Holdings: Execution of single sales/supply contract (Major management matters of subsidiary)
AI reading
★★★ Bullish · Contract win
Subsidiary BTI-Gen signs pharmaceutical contract manufacturing agreement
Key figures: Contract value ₩13.66bn (13.2% of revenue)
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
Other filings by Dong-A Socio Holdings
For information only. Not investment advice.